TABLE 1.
PULMONARY ARTERIAL DIAMETER AND FLOW
Control | P VTI (cm) | SD | PA D (cm) | SD | CSA (cm2) | SV (ml) |
uPA | 7.84 | 1.4 | 0.32 | 0.076 | 0.0804 | 0.63 |
uPa + peptide | 8.33 | 1.1 | 0.36 | 0.042 | 0.102 | 0.85 |
uPA + MK-801 | 7.97 | 1.7 | 0.33 | 0.054 | 0.0855 | 0.681 |
8.03 | 1.2 | 0.33 | 0.061 | 0.0855 | 0.686 |
Echocardiography was performed in five different Sprague-Dawley rats (Harlan Laboratories, Jerusalem, Israel) before and after intraperitoneal injections of urokinase-type plasminogen activator (uPA), as described in Materials and Methods. Pulmonary artery diameter (PA D) and the time velocity integral (P TVI), as a surrogate for stroke volume, were measured. The cross-sectional area (CSA) of the pulmonary artery and cardiac stroke volume (SV) were calculated using the formulas CSA = 0.785 × D2, and SV = CSA × TVI. All parameters were evaluated during an average of three consecutive beats. A single echocardiographer, blinded to the specific intervention, performed all data acquisition.